4502:TYO
Takeda Pharmaceutical Co Ltd
5 780,00 JP¥
0,00%
(0,00) 1D
30 қыр., 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4502...
Mkt. cap
9,26 трлн
Avg. vol.
4,20 млн
Volume
0,00
Dividend
3,46%
Quarterly dividend
50 JP¥
Ex-dividend date
2026 ж. 29 қыр.
52-wk high
6 033 JP¥
52-wk low
4 102 JP¥
EPS
-103 JP¥
Shares outstanding
784,48 млн
No. of employees
47 мың
Mkt. cap
9,26 трлн
Avg. vol.
4,20 млн
Volume
0,00
Dividend
3,46%
Quarterly dividend
50 JP¥
Ex-dividend date
2026 ж. 29 қыр.
52-wk high
6 033 JP¥
52-wk low
4 102 JP¥
EPS
-103 JP¥
Shares outstanding
784,48 млн
No. of employees
47 мың
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 мың
Founded1781 ж. 12 мау.
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com